New Cancer Treatment Halts Disease in 94% of Terminal Patients in Trial! Is This THE Cure We've Been Waiting For?

Teresa Neumann : Feb 16, 2016
Andrew Gregory - The Mirror UK

"This is extraordinary. It is unprecedented in medicine to get response rates in this range in these very advanced patients. These are patients that have failed everything. Most would be projected to have two to five months to live." -Professor Stanley Riddell

(Seattle, WA)—Cancer doctors are "hailing" a revolutionary new treatment that allows the human body to kill cancer all by itself. (Photo via Mirror.UK)

The breakthrough—a combination of work pioneered by Professor Stanley Riddell of the Fred Hutchinson Cancer Research Center in Seattle and a team of doctors from Italy—centers around the manipulation of white blood cells, also known as T-cells.

It's called immunotherapy.

In essence, T-cells were removed from the blood of patients in the cancer trial and then genetically "modified" before being injected back into the patient.

Doctors and researchers were astonished by the results.

"This is extraordinary," said Professor Riddell. "It is unprecedented in medicine, to be honest, to get response rates in this range in these very advanced patients. (Photo: a killer T-Lymphocyte approaches a cancer cell/Coneyl Jay)

"These are in patients that have failed everything. Most would be projected to have two to five months to live. This is potentially paradigm-shifting in terms of how we treat them.

"I think immunotherapy has finally made it to a pillar of cancer therapy."

Although the study was originally conducted on blood cancers, Riddell's team is also working on using T-cell technology in targeting solid tumors.

To read more of this amazing breakthrough, including how Italian researchers are excited about developing a vaccine to maintain the body's anti-cancer fighting defenses, click here.